Atea Pharmaceuticals (AVIR) Depreciation & Amortization (CF) (2019 - 2026)
Atea Pharmaceuticals (AVIR) posted quarterly Depreciation & Amortization (CF) of $104000.0 for Q1 2026, little changed year-over-year from $104000.0 in Q1 2025, and little changed quarter-over-quarter from $104000.0 in Q4 2025.
Powered by 
Analysis
Atea Pharmaceuticals (AVIR) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Atea Pharmaceuticals' Depreciation & Amortization (CF) history runs 8 years deep, the most recent figure standing at $104000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) changed 0.0% year-over-year to $104000.0; the TTM figure through Mar 2026 stood at $416000.0 (changed 0.0% YoY), while the FY2025 annual figure was $416000.0, changed 0.0% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $104000.0, roughly flat from $104000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $106000.0 in Q3 2022, with the low at $7000.0 in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $104000.0 (2022), against an average of $94823.5.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) soared 1414.29% in 2022, then slipped 1.89% in 2023.
- Atea Pharmaceuticals' Depreciation & Amortization (CF) stood at $104000.0 in 2022, then changed by 0.0% to $104000.0 in 2023, then changed by 0.0% to $104000.0 in 2024, then changed by 0.0% to $104000.0 in 2025, then changed by 0.0% to $104000.0 in 2026.
- Business Quant data shows AVIR's Depreciation & Amortization (CF) at $104000.0 in Q1 2026, $104000.0 in Q4 2025, and $104000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Atea Pharmaceuticals | 467.50 Mn | 467.50 Mn | - | 104,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 104,000.00 |
| Mar 31, 2026 | 104,000.00 |
| Dec 31, 2025 | 104,000.00 |
| Sep 30, 2025 | 104,000.00 |
| Jun 30, 2025 | 104,000.00 |
| Mar 31, 2025 | 104,000.00 |
| Dec 31, 2024 | 104,000.00 |
| Sep 30, 2024 | 104,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Mar 31, 2024 | 104,000.00 |
| Dec 31, 2023 | 104,000.00 |
| Sep 30, 2023 | 104,000.00 |
| Jun 30, 2023 | 104,000.00 |
| Mar 31, 2023 | 104,000.00 |
| Dec 31, 2022 | 104,000.00 |
| Sep 30, 2022 | 106,000.00 |
| Jun 30, 2022 | 43,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 7,000.00 |